DOI: 10.1055/s-00000134

Diabetologie und Stoffwechsel

References

Fitchett D, Zinman B, Wanner C. et al.
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial.

Eur Heart J 2016;
37: 1526-1534

Download Bibliographical Data

Access: